IHC staining of PARP1 in xenograft tumor tissues showed consistent results, indicating that sesamin treatment activated PARP1 levels both in vitro and in vivo(Fig. 6B; Supplementary Fig. 1D). The gene discussed is PARP1; the disease is neoplasm.